GenPharm International Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

GenPharm International General Information

Description

Developer of fully human monoclonal antibodies based on transgenic animal technology. The company also produces HuMAb-Mouse (tm) transgenic system for the production of fully human MAbs. The company applies transgenic animal technology to the development of human antibody products for therapeutic uses.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 855 California Avenue
  • Palo Alto, CA 94304
  • United States
+1 (415)
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • 855 California Avenue
  • Palo Alto, CA 94304
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GenPharm International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Oct-1997 Completed Generating Revenue
1. Early Stage VC Completed Startup
To view GenPharm International’s complete valuation and funding history, request access »

GenPharm International Patents

GenPharm International Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2005276787-A1 Binding member towards pneumolysin Inactive 23-Aug-2004
EP-1791867-A2 Binding member towards pneumolysin Inactive 23-Aug-2004
US-20090214547-A1 Binding member towards pneumolysin Inactive 23-Aug-2004
EP-1646654-A1 Binding member towards pneumococcus surface adhesin a protein (psaa) Inactive 08-Jul-2003
US-20070003561-A1 Binding member towards pneumococcus surface adhesin a protein (psaa) Inactive 08-Jul-2003 C07K16/1275
To view GenPharm International’s complete patent history, request access »

GenPharm International Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Abingworth Venture Capital Minority
Atlas Venture Venture Capital Minority
Avalon Ventures Venture Capital Minority
Charterhouse Capital Partners PE/Buyout Minority
Collagen Corporation Corporation Minority
You’re viewing 5 of 20 investors. Get the full list »

GenPharm International FAQs

  • When was GenPharm International founded?

    GenPharm International was founded in 1989.

  • Where is GenPharm International headquartered?

    GenPharm International is headquartered in Palo Alto, CA.

  • What industry is GenPharm International in?

    GenPharm International’s primary industry is Biotechnology.

  • Is GenPharm International a private or public company?

    GenPharm International is a Private company.

  • What is GenPharm International’s current revenue?

    The current revenue for GenPharm International is .

  • Who are GenPharm International’s investors?

    Abingworth, Atlas Venture, Avalon Ventures, Charterhouse Capital Partners, and Collagen Corporation are 5 of 20 investors who have invested in GenPharm International.

  • When was GenPharm International acquired?

    GenPharm International was acquired on 01-Oct-1997.

  • Who acquired GenPharm International?

    GenPharm International was acquired by Medarex.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process